Cybin Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 Douglas Drysdale	CEO	Reveal Email/Phone
2 John Kanakis	Co-founder	Reveal Email/Phone
3 Emma Hodge	Head Legal Europe	Reveal Email/Phone
4 Marie Layzell	Head Analytical and Formulation Development	Reveal Email/Phone
5 Mirza Rahman	SVP, Patient Safety & Pharmacovigilance, President	Reveal Email/Phone
6 Tom Macek	SVP Clinical Development	Reveal Email/Phone
7 Ellen James	Director, Clinical Development	Reveal Email/Phone
8 Angela Sorie	Sr Director, Clinical Programs	Reveal Email/Phone
9 Joseph Cheung	Director Financial Planning and Analysis	Reveal Email/Phone
10 Aaron Bartlone	Chief Operating Officer	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 MindMed	$20M	129	11%	N/A	N/A
#2 Compass	$6040M	30039	5%	$1.5B	$3.3B
#3 Numinus	$7.5M	90	53%	N/A	N/A

Cybin is a biotech company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions.

keywords:N/A

N/A

Total Funding

Number of Employees

$14.3M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists,...

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder.

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT. - Delivery of CYB004 via inhalation...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Hart House Inve...	$19.3M	92	16%	N/A
#2 ISA (Informatio...	$13.3M	92	16%	N/A
#3 MindBeacon	$56.3M	92	-12%	$33.7M
#4 Your Choice Rea...	$13.8M	92	-12%	N/A
#5 Americas Silver...	$22.5M	92	3%	$85.9M